ArticleJournal of clinical medicine2022

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy.

Marco Cefalì et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.